News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

ARTISTRY-1 supports switch from complex HIV regimen to a novel single pill
04 Mar 2026
byAudrey Abella
The phase II/III open-label ARTISTRY-1 trial shows that people living with HIV (PWH) may simplify their complex regimen (CR) by switching to a novel daily single-tablet regimen (STR) comprising bictegravir and lenacapavir (BIC+LEN).








